ORTH ANDREW C. has filed 7 insider transactions across 1 company since February 2023.
Most recent transaction: a option exercise of 12500 shares of Krystal Biotech, Inc. ($KRYS) on June 09, 2023.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 9, 2023 | Krystal Biotech, Inc. | $KRYS | ORTH ANDREW C. | Chief Commercial Officer | M | Common Stock | 12500 | $63.55 | 12,600.0000 | 25,492,000 | 9999.99% | 0.05% |
| June 9, 2023 | Krystal Biotech, Inc. | $KRYS | ORTH ANDREW C. | Chief Commercial Officer | S | Common Stock | 5261 | $128.10 | 7,339.0000 | 25,492,000 | 41.75% | 0.02% |
| June 9, 2023 | Krystal Biotech, Inc. | $KRYS | ORTH ANDREW C. | Chief Commercial Officer | S | Common Stock | 6906 | $128.94 | 433.0000 | 25,492,000 | 94.10% | 0.03% |
| June 9, 2023 | Krystal Biotech, Inc. | $KRYS | ORTH ANDREW C. | Chief Commercial Officer | S | Common Stock | 333 | $129.70 | 100.0000 | 25,492,000 | 76.91% | 0.00% |
| June 9, 2023 | Krystal Biotech, Inc. | $KRYS | ORTH ANDREW C. | Chief Commercial Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 37,500.0000 | 25,492,000 | 25.00% | 0.05% |
| Feb. 28, 2023 | Krystal Biotech, Inc. | $KRYS | ORTH ANDREW C. | Chief Commercial Officer | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 25,492,000 | 9999.99% | 0.08% |
| Feb. 28, 2023 | Krystal Biotech, Inc. | $KRYS | ORTH ANDREW C. | Chief Commercial Officer | A | Performance Stock Units | 10000 | $0.00 | 10,000.0000 | 25,492,000 | 9999.99% | 0.04% |